药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Rescinnamine
Inotersen
The risk or severity of QTc prolongation can be increased when Inotersen is combined with Panobinostat.
Rescinnamine
Pipemidic acid
The risk or severity of QTc prolongation can be increased when Pipemidic acid is combined with Panobinostat.
Rescinnamine
Rufloxacin
The risk or severity of QTc prolongation can be increased when Rufloxacin is combined with Panobinostat.
Rescinnamine
Lidoflazine
The risk or severity of QTc prolongation can be increased when Lidoflazine is combined with Panobinostat.
Rescinnamine
Piromidic acid
The risk or severity of QTc prolongation can be increased when Piromidic acid is combined with Panobinostat.
Rescinnamine
Acetyldigoxin
The risk or severity of QTc prolongation can be increased when Acetyldigoxin is combined with Panobinostat.
Rescinnamine
Lorajmine
The risk or severity of QTc prolongation can be increased when Lorajmine is combined with Panobinostat.
Rescinnamine
Oxolinic acid
The risk or severity of QTc prolongation can be increased when Oxolinic acid is combined with Panobinostat.
Rescinnamine
Prajmaline
The risk or severity of QTc prolongation can be increased when Prajmaline is combined with Panobinostat.
Rescinnamine
Bencyclane
The risk or severity of QTc prolongation can be increased when Bencyclane is combined with Panobinostat.
Rescinnamine
Cibenzoline
The risk or severity of QTc prolongation can be increased when Cibenzoline is combined with Panobinostat.
Rescinnamine
Cicletanine
The risk or severity of QTc prolongation can be increased when Cicletanine is combined with Panobinostat.
Rescinnamine
Pilsicainide
The risk or severity of QTc prolongation can be increased when Pilsicainide is combined with Panobinostat.
Rescinnamine
Givinostat
The risk or severity of QTc prolongation can be increased when Givinostat is combined with Panobinostat.
Rescinnamine
Temefos
The risk or severity of QTc prolongation can be increased when Temefos is combined with Panobinostat.
Rescinnamine
Tetrahydropalmatine
The risk or severity of QTc prolongation can be increased when Tetrahydropalmatine is combined with Panobinostat.
Rescinnamine
Delafloxacin
The risk or severity of QTc prolongation can be increased when Delafloxacin is combined with Panobinostat.
Rescinnamine
Prulifloxacin
The risk or severity of QTc prolongation can be increased when Prulifloxacin is combined with Panobinostat.
Rescinnamine
CUDC-907
The risk or severity of QTc prolongation can be increased when CUDC-907 is combined with Panobinostat.
Rescinnamine
Pazufloxacin
The risk or severity of QTc prolongation can be increased when Pazufloxacin is combined with Panobinostat.